Analysts Set Teladoc Health, Inc. (NYSE:TDOC) Price Target at $11.26

Teladoc Health, Inc. (NYSE:TDOC - Get Free Report) has been given a consensus recommendation of "Hold" by the eighteen ratings firms that are presently covering the stock, MarketBeat reports. Eleven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $11.26.

A number of brokerages have recently weighed in on TDOC. Needham & Company LLC reissued a "hold" rating on shares of Teladoc Health in a report on Thursday, February 27th. The Goldman Sachs Group dropped their target price on Teladoc Health from $16.00 to $13.00 and set a "buy" rating on the stock in a research report on Monday, March 3rd. Royal Bank of Canada raised their price target on shares of Teladoc Health from $11.00 to $12.00 and gave the stock an "outperform" rating in a research report on Friday, January 24th. Bank of America increased their price objective on shares of Teladoc Health from $11.50 to $13.50 and gave the stock a "neutral" rating in a research note on Wednesday, February 12th. Finally, Oppenheimer decreased their target price on shares of Teladoc Health from $14.00 to $12.00 and set an "outperform" rating for the company in a research report on Friday, January 24th.

Teladoc Health Stock Up 3.1 %

Shares of Teladoc Health stock traded up $0.26 during trading on Tuesday, reaching $8.43. The company's stock had a trading volume of 4,785,232 shares, compared to its average volume of 6,021,915. The company has a 50-day simple moving average of $10.45 and a two-hundred day simple moving average of $9.72. Teladoc Health has a 1-year low of $6.76 and a 1-year high of $15.68. The company has a market cap of $1.46 billion, a price-to-earnings ratio of -1.46 and a beta of 1.27. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66.

Remove Ads

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The company had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. As a group, equities analysts forecast that Teladoc Health will post -1.16 earnings per share for the current year.

Hedge Funds Weigh In On Teladoc Health

Several institutional investors and hedge funds have recently bought and sold shares of TDOC. Wealth Enhancement Advisory Services LLC raised its position in shares of Teladoc Health by 22.1% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider's stock valued at $134,000 after buying an additional 2,662 shares during the period. PKO Investment Management Joint Stock Co purchased a new stake in Teladoc Health in the fourth quarter valued at $227,000. Brucke Financial Inc. purchased a new stake in Teladoc Health in the fourth quarter valued at $92,000. Vise Technologies Inc. lifted its stake in shares of Teladoc Health by 4.9% in the 4th quarter. Vise Technologies Inc. now owns 30,179 shares of the health services provider's stock valued at $274,000 after purchasing an additional 1,405 shares during the last quarter. Finally, PharVision Advisers LLC purchased a new position in shares of Teladoc Health during the 4th quarter worth $301,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.